Skip to main content
Quest Diagnostics

An Insulin Resistance Score Improved Diabetes Risk Assessment in the Malmö Prevention Project-A Longitudinal Population-Based Study of Older European

An Insulin Resistance Score Improved Diabetes Risk Assessment in the Malmö Prevention Project-A Longitudinal Population-Based Study of Older Europeans

Authors: Shiffman D, Louie JZ, Meigs JB, Devlin JJ, McPhaul MJ, Melander O.

Citation: Diabetes Care. 2021 Aug 6;dc211328. doi: 10.2337/dc21-1328. Online ahead of print

Specialties: Cardiology, Endocrinology, Cardiovascular disease

Download key summary

Related content

Publication
Insulin Resistance Probability Score and Incident Cardiovascular Disease
Conference Presentation
The LS-IM Score And Its Relation To Direct Measurements Of Insulin Resistance
Conference Presentation
Insulin resistance probability score and cardiovascular events in the elderly
Publication
Prognostic value of insulin resistance and hyperglycemia biomarkers for long-term risks of cardiometabolic outcomes
Publication
The relationship between insulin resistance and ion mobility lipoprotein fractions
Test FAQ
CardioIQ® Insulin Resistance Panel with Score

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.